NCT02274428View on ClinicalTrials.gov

Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

December 31, 2016

Conditions
Mesenchymal Stromal Cells
Interventions
DRUG

pneumostem

human umbilical cord blood derived mesenchymal stem cells

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT02274428 - Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With Intraventricular Hemorrhage | Biotech Hunter | Biotech Hunter